secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001193125-24-104896
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences gets Nasdaq extension to Aug 13, 2024 for 300 public holders; issues $50K note to sponsor
--------------------------------------------------------------------------------

- Received Nasdaq extension to demonstrate minimum 300 public holders by August 13, 2024; previously failed compliance.
- Issued $50,000 unsecured promissory note to sponsor Bellevue Global Life Sciences Investors LLC, non-interest bearing.
- Note due December 31, 2024 or upon initial business combination; principal forgiven if no deal consummated.
- Failure to meet Nasdaq public-holder requirement by deadline could result in delisting of securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/0001193125-24-104896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524104896/d828353d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-104896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer